[ad_1]
Fausto Carioti
The photograph does not change. Israel has already vaccinated 12.6% of its population, the United Kingdom 1.4% and the United States 1.3% (Benjamin Netanyahu, Boris Johnson and Donald Trump, who according to the chorus get it wrong. Never one) . Germany is at 0.3%, so in Berlin they are crucifying Angela Merkel, who in any case has already secured 30 million more doses from the Pfizer-BionTech consortium, regardless of the EU agreements, which require that each purchase for Brussels, from where the individual states are classified in proportion to the number of their inhabitants (this means that 13.5% of the new German doses, that is, more than 4 million, have been taken from the Italians, already that BionTech cannot produce more than this). The Italia of Giuseppe Conte and Domenico Arcuri injected the first dose to 0.15% of the population. Less than the world average and worse than Portugal, Estonia, Croatia, Iceland and Bahrain, to name a few countries that are not exactly scientific and industrial superpowers. At the current rate, 12,000 injections a day, the entire Italian population over 16 years of age, made up of 51.3 million people, would receive the two doses necessary for the first immunization in 23 years. That is, never, because the efficacy of the serum, although unknown, would expire much sooner.
Passing the pain
Following the best tradition, the government has put all the blame on the Regions: if the vaccinated are much less than the available vaccines, the fault lies with the governors who do not do their part. Convenient thesis for Conte, Arcuri and their cheerleaders, but which overlooks a not exactly secondary aspect: no matter how advanced the medical technology is, the anti-Covid serum is not inoculated into the body of Italians. We need precision syringes, which are in short supply. And you need someone who knows how to use them and has the ability to deal with problems that may arise before or after the injection, from panic attacks to any allergic reaction. Reason why vaccinations are planned to be carried out by “teams” made up of a doctor and four nurses at the administration points, active seven days a week, and by a doctor and a nurse for home administration, who it will take place five days a week. In short, specialized personnel. That is not there. And remedying it was the task of Arcuri, the extraordinary commissioner for the Covid emergency. Where is the procurement assistant? In the highest seas.
In the tables that he has provided, the submission of applications by doctors and nurses is scheduled for today, and between January 25 and 28 the selection and signing of contracts, which will be followed by rapid training with a view to their first day of presence. at the administration points, which will be between the 28th and the 30th of this month. As Nino Cartabellotta, president of the Gimbe Foundation writes, “many (rightly) complain about the low percentage of vaccinated people compared to the doses delivered to the Regions, few know that the Regions will be able to use the” cavalry “not before the end from January”. A similar discourse refers to syringes. “From the first day we will have all the necessary to administer the vaccines,” Arcuri had guaranteed on December 10. It has been seen. Liguria, for example, only received the 5 and 3 milliliters, which are good for diluting the drug, not for administering it. «For this operation», explains Governor Giovanni Toti, «we need 1 milliliter syringes. The Liguria Region had them at home, so there was no impact on our vaccination campaign, but we would need more attention from the government. Those who didn’t have ready strains, like Calabria, are in trouble. The rest of the disaster is the result of European mistakes. It’s rare for an entrepreneur to complain about the lack of competitors willing to steal market share, but that’s what Ugur Sahin and Özlem Türeci, the two Turkish-born scientists who founded BionTech, the company that developed the commercialized anti-Covid vaccine, say. together with the American company Pfizer: to date, the only one authorized in the European Union.
EU ERRORS
Interviewed by the weekly Der Spiegel, they accused the EU of having miscalculated all the calculations. “The situation is not good,” they explain. “A hole has been created because other approved vaccines are missing and we have to close the gap with our vaccine.” The European Commission was convinced that there would be “multiple suppliers”, instead “at one point it became clear that many would not be able to supply the vaccines quickly”, but at that point “it was too late to remedy” insufficient “orders. Also because, in the meantime, Donald Trump had accumulated doses for his compatriots. So we wait on January 6, waiting for Ema, the European Medicines Agency, to give the green light to the Modern American serum, already authorized in the United States. Good news that unfortunately will not be decisive: Italy would have 10.8 million doses, which should arrive in September. Little compared to the 40.4 million doses that the French of Sanofi could not deliver and the 40.4 million of the supply promised by AstraZeneca Whose product, still blocked by the EMA, just today begins to be distributed in the United Kingdom.
[ad_2]
